期刊文献+

201例结核病患者分离株的药敏结果分析 被引量:4

Analysis of drug susceptibility in 201 tuberculosis patients
下载PDF
导出
摘要 本文旨在分析2008年12月~2009年5月就诊于上海市肺科医院的201例结核病患者结核分枝杆菌的药敏试验结果。结核分枝杆菌培养采用罗氏培养系统,药敏试验采用绝对浓度法。201例患者中,耐药率由高到低依次为异烟肼(INH,52.24%)、链霉素(SM,45.77%)、利福平(RFP,30.35%)、乙胺丁醇(EMB,28.86%)、阿米卡星(AK,28.18%)、利福喷汀(RIB,26.40%)、力克肺疾(Pa,25.56%)、对氨基水杨酸(PAS,23.60%)、丙硫异烟胺(Pt,23.03%)、卷曲霉素(CPM,20.56%)。其中,初治患者的耐药率为3.08%~26.15%,复治患者为27.50%~64.71%,耐多药患者为64.44%~100%。总体来看,与低浓度相比,高浓度SM、INH、EMB、RIB、Pt可明显降低结核分枝杆菌的耐药率(P<0.05)。除INH、SM、RFP外,女性患者的耐药率均高于男性,耐多药率亦高于男性(P<0.05)。结果提示,临床上应足量应用抗结核药物,对女性结核病患者要给予更多关注。 The paper aims to investigate the susceptibility test results of 201tuberculosis patients in Shanghai Pulmonary Hospital from December 2008to May 2009.Roche system was used to culture Mycobacterium tuberculosis(M.tuberculosis),and absolute concentration method was used to test drug susceptibility.In 201patients,the resistance rates of M.tuberculosis were as follows:isoniazid (INH,52.24%),streptomycin(SM,45.77%),rifampicin(RFP,30.35%),ethambutol(EMB,28.86%),amikacin(AK,28.18%),rifapentine (RIB,26.40%),pasiniazide (Pa,25.56%),paraminosalicylic acid (PAS,23.60%),protionamide(Pt,23.03%),capreomycin (CPM,20.56%).Among all the patients,drug resistance rates in patients being treated for the first time was 3.08%-26.15%,whereas in previouslytreated patients the rate was 27.50%-64.71%,and in multidrug-resistant patients the rate was 64.44%100%.Overall,compared with low concentrations of drugs,high concentrations of SM,INH,EMB,RIB,and Pt decreased the resistance rate of M.tuberculosis significantly(P0.05).Except for INH,SM,and RFP,higher drug resistance rates and multidrug resistance rates were observed in females compared with males(P0.05).These results suggest that the application of anti-tuberculosis drugs should be clinically adequate,and more attention should be paid to gender-related differences in drug resistance.
出处 《微生物与感染》 2010年第3期146-150,共5页 Journal of Microbes and Infections
关键词 结核 药敏试验 耐药 Tuberculosis Drug susceptibility test Drug resistance
  • 相关文献

参考文献9

  • 1WHO.The Globe MDR-TB and XDR-TB Response Plan 2007-2008[M/OL].
  • 2中国防痨协会基础专业委员会.结核病诊断实验室检验规程[M].深圳:中国教育文化出版社,2006,46-49.
  • 3中华人民共和国卫生部.2000年全国结核病流行病学抽样调查资料汇编[M].北京:人民卫生出版社,2001,46-47.
  • 4马玙.结核病的化学治疗及面临的挑战[J].中国医学科学院学报,2009,31(4):389-392. 被引量:21
  • 5WHO.Weight-based dosing of drugs for adults,Guidelines for the programmatic management of drug-resistant tuberculosis.Emergency update 2008[M/OL].193-194.http://whqlibdoc.who.int/publications/2008/9789241547581_eng.pdf.
  • 6Shen X,DeRiemer K,Yuan ZA,Shen M,Xia Z,Gui X,Wang L,Gao Q,Mei J.Drug-resistant tuberculosis in Shanghai,China,2000-2006:prevalence,trends and risk factors[J].Int J Tuberc Lung Dis,2009,13 (2):253-259.
  • 7Lomtadze N,Aspindzelashvili R,Janjgava M,Mirtskhulava V,Wright A,Blumberg HM,Salakaia A.Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia:a population-based study[J].Int J Tuberc Lung Dis,2009,13(1):68-73.
  • 8顾瑾 王凯 唐神结.152例耐多药肺结核的临床观察.中华实用医药杂志,2009,9(3):172-174.
  • 9何广学,谢艳光,任育麟,王莉,马世文.我国耐多药结核病高负担地区耐多药结核病人的性别和年龄分布特征[J].中国健康教育,2008,24(6):413-415. 被引量:19

二级参考文献20

  • 1安燕生,丁北川,朱建华,邢青,贺晓新,靳敏芝,罗平,王甦民.北京市WHO结核病药物耐药性监测研究[J].中国防痨杂志,2007,29(6):475-478. 被引量:22
  • 2World Health Organization.World Health Organization Global Tuberculosis Control (2009)[M].Geneva:WHO,2009:1145.
  • 3World Health Organization.World Health Organization Guidelines for the programmatic management of drug-resistant tuberculosis.Emergeny update,2008[M].Geneva:WHO,2008:ix-x.
  • 4McCune RM,Fcldman FM,McDermott W.Microbial persistence L The capacity of tubercle bacilli to survive sterilization in mouse tissue[J].J Exp Med,1966,123(3):445-468.
  • 5McCune RM,Feldman FM,McDermott W.Microbial persistence Ⅱ.Characteristics of the sterile state of tubercle bacilli[J].J Exp Med,1966,123(3):469-486.
  • 6Shamputa IC,Jugheli L,Sadradze N,et al.Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia[J].Respir Res,2006,7:99-108.
  • 7王甦民,刘宇红,姜广路,刘洋,付育红,端木宏谨.世界卫生组织中国结核病耐药监测的结果评价[J].中华检验医学杂志,2007,30(8):863-866. 被引量:48
  • 8梅建,沈鑫,沈梅,桂晓虹,孙斌.上海市结核分枝杆菌耐药性监测研究报告[J].中国防痨杂志,2007,29(5):395-398. 被引量:42
  • 9World Health Organization. Anti-tuberculosis drug resistance in the world. Report no. 4. WHO/HTM/TB/2008. 394[R]. Geneva: World Health Organization, 2008.
  • 10World Health Organization. Global MDR - TB & XDR- TB Response Plan 2007 - 2008. WHO/HTM/TB/2007. 387 [ R]. Geneva: World Health Organization,2007.

共引文献45

同被引文献33

  • 1结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(2):80-85. 被引量:78
  • 2中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年)[M].北京:人民卫生出版社,2010:25-52.
  • 3Dye C,Scheele S,Dolin P,et al.for the Global Surveillanceand Monitoring Project:Global burden of tuberculosis:estimated incidence,prevalence and mortality by country[J].JAMA,1999,282:677-686.
  • 4中国防痨协会基础专业委员会.结核病诊断实验室检验规程[M].北京:中国教育出版社,2006.13-16.
  • 5中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007年-2008年)[M].2010,北京:人民卫生出版社,2010:27,1—26.
  • 6中华人民共和国卫生部疾病预防控制局,中国疾病预防控制中心.中国结核病防治规划痰涂片镜检标准化操作及质量保证手册[M].北京:中国协和医科大学出版社.2008:2-24.
  • 7中华人民共和国卫生部疾病预防控制局,中国疾病预防控制中心.全国第五次结核病流行病学抽样调查资料汇编[M].北京军事医学科学出版社,2011:3-49.
  • 8林辉,刘洁,陈林,王志斌,靖宽和,沈静,詹建,熊鸿燕,曹佳.重庆市2003-2006年肺结核病耐药情况分析[J].第三军医大学学报,2008,30(12):1183-1185. 被引量:31
  • 9徐妍,王莉,朱雅娟,苏新明.202例肺结核患者痰培养阳性菌株耐药性分析[J].中国感染控制杂志,2009,8(1):14-17. 被引量:5
  • 10张楠,胡继红,万康林.乙胺丁醇耐药表型与耐药基因embB突变的关系[J].中国卫生检验杂志,2010,20(3):490-492. 被引量:11

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部